THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,354,428 | -16.6% | 7,457,060 | 0.0% | 3.81% | -35.6% |
| Q2 2023 | $77,180,571 | -4.6% | 7,457,060 | 0.0% | 5.92% | +14.3% |
| Q1 2023 | $80,909,101 | -3.3% | 7,457,060 | 0.0% | 5.18% | +51.9% |
| Q4 2022 | $83,668,213 | +10.7% | 7,457,060 | 0.0% | 3.41% | +83.4% |
| Q3 2022 | $75,615,000 | +33.8% | 7,457,060 | +19.6% | 1.86% | +34.6% |
| Q2 2022 | $56,511,000 | +9.2% | 6,237,438 | +15.2% | 1.38% | +28.6% |
| Q1 2022 | $51,743,000 | +80.0% | 5,412,487 | +108.0% | 1.07% | +74.2% |
| Q4 2021 | $28,750,000 | – | 2,601,778 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |